Evotec SE (ETR:EVT – Get Free Report)’s stock price dropped 1.3% on Thursday . The stock traded as low as €6.30 ($6.77) and last traded at €6.32 ($6.79). Approximately 509,397 shares were traded during mid-day trading, a decline of 63% from the average daily volume of 1,360,000 shares. The stock had previously closed at €6.40 ($6.88).
Evotec Stock Performance
The stock has a market capitalization of $1.17 billion, a price-to-earnings ratio of -6.83, a price-to-earnings-growth ratio of 0.98 and a beta of 1.05. The business’s 50 day simple moving average is €7.76 and its 200-day simple moving average is €7.64.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Read More
- Five stocks we like better than Evotec
- Stock Market Sectors: What Are They and How Many Are There?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Buy P&G Now, Before It Sets A New All-Time High
- Top 3 Beverage Stocks Pouring Out Profits
- Conference Calls and Individual Investors
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
